Log in to save to my catalogue

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humor...

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humor...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8a6e2bdaa5404154a54ecf8fcb54843c

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

About this item

Full title

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

Publisher

England: BioMed Central

Journal title

BMC infectious diseases, 2023-05, Vol.23 (1), p.332-332, Article 332

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs) may have impaired long-term humoral immune responses and increased disease activity after SARS-CoV-2 infection. We aimed to investigate long-term humoral immune responses against SARS-CoV-2 and increased disease activity after a primary SARS-CoV-2 infection in...

Alternative Titles

Full title

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8a6e2bdaa5404154a54ecf8fcb54843c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8a6e2bdaa5404154a54ecf8fcb54843c

Other Identifiers

ISSN

1471-2334

E-ISSN

1471-2334

DOI

10.1186/s12879-023-08298-6

How to access this item